H1N2 is a subtype of the species Influenza A virus (sometimes called bird flu virus). It is currently pandemic in both human and pig populations.
H1N1, H1N2, and H3N2 are the only known Influenza A virus subtypes currently circulating among humans.
The virus does not cause more severe illness than other influenza viruses, and no unusual increases in influenza activity have been associated with it.
Between December 1988 and March 1989, 19 influenza H1N2
virus isolates were identified in 6 cities in China, but the virus did
not spread further.
A(H1N2) was identified during the 2001-2002 flu season
(northern hemisphere) in Canada, the U.S.A., Ireland, Latvia, France,
Romania, Oman, India, Malaysia, and Singapore with earliest documented
outbreak of the virus occurring in India on May 31, 2001
On February 6, 2002, the World Health Organization (WHO) in
Geneva and the Public Health Laboratory Service (PHLS) in the United
Kingdom reported the identification influenza A(H1N2) virus from humans
in the UK, Israel, and Egypt.
The 2001-2002 Influenza A(H1N2) ''Wisconsin'' strain appears
to have resulted from the reassortment of the genes of the currently
circulating influenza A(H1N1) and A(H3N2) subtypes.
Because the hemagglutinin protein of the virus is similar to
that of the currently circulating A(H1N1) viruses and the neuraminidase
protein is similar to that of the current A(H3N2) viruses, the seasonal
flu vaccine should provide good protection against influenza virus as
well as protection against the currently circulating seasonal A(H1N1),
A(H3N2), and B viruses.
This article is licensed under the Creative Commons Attribution-ShareAlike License.
It uses material from the Wikipedia article on
"Influenza A virus subtype H1N2"
All material adapted used from Wikipedia is available under the terms of the
Creative Commons Attribution-ShareAlike License.
Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.